282 related articles for article (PubMed ID: 29293555)
1. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
2. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
3. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract][Full Text] [Related]
4. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.
Yan K; Gao J; Yang T; Ma Q; Qiu X; Fan Q; Ma B
PLoS One; 2012; 7(3):e33778. PubMed ID: 22457788
[TBL] [Abstract][Full Text] [Related]
6. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
8. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
9. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
10. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
[TBL] [Abstract][Full Text] [Related]
11. miR-196a expression in human and canine osteosarcomas: a comparative study.
Pazzaglia L; Leonardi L; Conti A; Novello C; Quattrini I; Montanini L; Roperto F; Del Piero F; Di Guardo G; Piro F; Picci P; Benassi MS
Res Vet Sci; 2015 Apr; 99():112-9. PubMed ID: 25599934
[TBL] [Abstract][Full Text] [Related]
12. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.
Fenger JM; Bear MD; Volinia S; Lin TY; Harrington BK; London CA; Kisseberth WC
BMC Cancer; 2014 Feb; 14():84. PubMed ID: 24517413
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
15. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
16. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.
Zhao H; Ma B; Wang Y; Han T; Zheng L; Sun C; Liu T; Zhang Y; Qiu X; Fan Q
Oncol Rep; 2013 Mar; 29(3):1027-36. PubMed ID: 23314380
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.
Chen G; Fang T; Huang Z; Qi Y; Du S; Di T; Lei Z; Zhang X; Yan W
Cell Physiol Biochem; 2016; 38(2):598-608. PubMed ID: 26845446
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
Wen J; Zhao YK; Liu Y; Zhao JF
Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
Sun Z; Zhang T; Chen B
Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
